← Evidence map

ArticlePloS one2018

Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model.

Nadim Mahmud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2018
2019
2020
2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30496309